title: Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Cancer Medicine.
authors.forename: M J
authors.initials: MJ
authors.lastname: Seckl
authors.forename: N J
authors.initials: NJ
authors.lastname: Sebire
authors.forename: R A
authors.initials: RA
authors.lastname: Fisher
authors.forename: F
authors.initials: F
authors.lastname: Golfier
authors.forename: L
authors.initials: L
authors.lastname: Massuger
authors.forename: C
authors.initials: C
authors.lastname: Sessa
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002822:Choriocarcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006063:Chorionic Gonadotropin / Q000097:blood / Q000652:urine; D019008:Drug Resistance, Neoplasm; D005060:Europe / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D006828:Hydatidiform Mole / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D011506:Proteins / Q000235:genetics; D012306:Risk; D018570:Risk Assessment
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin; C568062:KHDC3L protein, human; C502448:NLRP7 protein, human; D011506:Proteins